RBC Capital Markets’s $262 target on RMD

RMD ResMed

$229 → $262 (+14%) by Sep 2027

Outperform · raises · said Sep 15, 2026 · 12-month default horizon

Open: judged on the close on Sep 15, 2027

The article this target came from

ResMed stock jumps 3% on RBC Capital upgrade to Outperform

Investing.com · Sep 15, 2026

increased the price target to $262 from $244.

RBC Capital Markets’s track record → ResMed →

A fact about what RBC Capital Markets published, as reported by Investing.com, not a recommendation from Dalsna Finance; RBC Capital Markets is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.